These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11669606)

  • 21. Role of LMP1 in immune control of EBV infection.
    Pai S; Khanna R
    Semin Cancer Biol; 2001 Dec; 11(6):455-60. PubMed ID: 11669607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production.
    Xu D; Brumm K; Zhang L
    J Biol Chem; 2006 Apr; 281(14):9163-9. PubMed ID: 16469740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia.
    Niller HH; Wolf H; Minarovits J
    Semin Cancer Biol; 2009 Jun; 19(3):158-64. PubMed ID: 19429479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus latency: LMP2, a regulator or means for Epstein-Barr virus persistence?
    Longnecker R
    Adv Cancer Res; 2000; 79():175-200. PubMed ID: 10818681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus.
    Martin HJ; Lee JM; Walls D; Hayward SD
    J Virol; 2007 Sep; 81(18):9748-58. PubMed ID: 17609264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene.
    Walling DM; Shebib N; Weaver SC; Nichols CM; Flaitz CM; Webster-Cyriaque J
    J Infect Dis; 1999 Apr; 179(4):763-74. PubMed ID: 10068570
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Epstein-Barr virus and cellular immortalization].
    Marechal V; Dehée A; Nicolas JC
    Ann Med Interne (Paris); 1997; 148(5):367-71. PubMed ID: 9538410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma.
    Liu JP; Cassar L; Pinto A; Li H
    Cell Res; 2006 Oct; 16(10):809-17. PubMed ID: 17016469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes.
    Xu D; Zhao L; Del Valle L; Miklossy J; Zhang L
    J Virol; 2008 Jul; 82(13):6251-8. PubMed ID: 18417578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
    Wang Y; Luo B; Zhao P; Huang BH
    Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells.
    Liu MT; Chen YR; Chen SC; Hu CY; Lin CS; Chang YT; Wang WB; Chen JY
    Oncogene; 2004 Apr; 23(14):2531-9. PubMed ID: 14716302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncogenic activity of Epstein-Barr virus latent membrane protein 1 (LMP-1) is down-regulated by lytic LMP-1.
    Pandya J; Walling DM
    J Virol; 2006 Aug; 80(16):8038-46. PubMed ID: 16873260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Inhibiting target gene expression and controlling growth of Epstein-Barr virus transformed cells by antisense RNA transcripts].
    Chen JJ; Raab-Traub N; Yao QY; Zhang F; Huang ML; Kuang ZJ; Zhang XS; Ye YL; Gu L
    Ai Zheng; 2002 Jan; 21(1):16-20. PubMed ID: 12500390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Latent and lytic Epstein-Barr virus replication strategies.
    Tsurumi T; Fujita M; Kudoh A
    Rev Med Virol; 2005; 15(1):3-15. PubMed ID: 15386591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EBV transformation overrides gene expression patterns of B cell differentiation stages.
    Siemer D; Kurth J; Lang S; Lehnerdt G; Stanelle J; Küppers R
    Mol Immunol; 2008 Jun; 45(11):3133-41. PubMed ID: 18430472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High frequency of Epstein Barr virus latent membrane protein-1 30 bp deletion in a series of pediatric malignancies in Argentina.
    Chabay P; De Matteo E; Merediz A; Preciado MV
    Arch Virol; 2004 Aug; 149(8):1515-26. PubMed ID: 15290377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency.
    Zhang L; Pagano JS
    Mol Cell Biol; 1999 Apr; 19(4):3216-23. PubMed ID: 10082588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection.
    Kubota N; Wada K; Ito Y; Shimoyama Y; Nakamura S; Nishiyama Y; Kimura H
    J Virol Methods; 2008 Jan; 147(1):26-36. PubMed ID: 17870188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.
    Zhang L; Wu L; Hong K; Pagano JS
    J Virol; 2001 Dec; 75(24):12393-401. PubMed ID: 11711629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1.
    Zhang L; Pagano JS
    J Virol; 2001 Jan; 75(1):341-50. PubMed ID: 11119603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.